A space for sharing and discussing news related to global current events, technology, and society.
69530 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
69530 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
39.8K
0
39.8K
"The US Food and Drug Administration authorized Novavax's Covid-19 vaccine on Friday for emergency use in adolescents. It is the fourth coronavirus vaccine available in the United States and, unlike the others, is uses a protein-based _...Read More_
"The US Food and Drug Administration authorized Novavax's Covid-19 vaccine on Friday for emergency use in adolescents. It is the fourth coronavirus vaccine available in the United States and, unlike the others, is uses a protein-based _...Read More_
0
205
0
205
"A federal advisory committee on Tuesday voted to recommend that regulators authorize a Covid-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program."
"A federal advisory committee on Tuesday voted to recommend that regulators authorize a Covid-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program."
0
12.6K
0
12.6K
"The vaccine, made by Novavax, Inc., of Gaithersburg, Md., was about 90% effective at preventing mild, moderate and severe COVID-19 when tested in a study involving about 30,000 volunteers ages 18 and older, according to the FDA."
"The vaccine, made by Novavax, Inc., of Gaithersburg, Md., was about 90% effective at preventing mild, moderate and severe COVID-19 when tested in a study involving about 30,000 volunteers ages 18 and older, according to the FDA."
0
81.7
0
81.7
>"Nuvaxovid is similar to flu jab and may have reduced side-effects, which could persuade vaccine holdouts"
>"Nuvaxovid is similar to flu jab and may have reduced side-effects, which could persuade vaccine holdouts"
0
70.1
0
70.1
The vaccine could be in high demand. Novavax’s vaccine is protein based, using an alternative technology to the more widespread mRNA vaccines. Skeptics leery of the mRNA technology may be inclined to get the Novavax version, Erck said, _...Read More_
The vaccine could be in high demand. Novavax’s vaccine is protein based, using an alternative technology to the more widespread mRNA vaccines. Skeptics leery of the mRNA technology may be inclined to get the Novavax version, Erck said, _...Read More_
0
325
0
325
Novavax said its vaccine would contain the mutated spike protein in the omicron variant so individuals can develop an immune response, a company _...Read More_
Novavax said its vaccine would contain the mutated spike protein in the omicron variant so individuals can develop an immune response, a company _...Read More_
0
355
0
355
"Pfizer, AstraZeneca, Moderna. Britons have become so accustomed to the three Covid vaccines available in the UK that most have _...Read More_
"Pfizer, AstraZeneca, Moderna. Britons have become so accustomed to the three Covid vaccines available in the UK that most have _...Read More_
0
19.2
0
19.2
Novavax Inc’s coronavirus vaccine was 96% effective in preventing cases caused by _...Read More_
Novavax Inc’s coronavirus vaccine was 96% effective in preventing cases caused by _...Read More_
0
116
0
116
[https://amp.cnn.com/cnn/2020/09/02/health/novavax-vaccine-safe/index.html](https://amp.cnn.com/cnn/2020/09/02/health/novavax-vaccine-safe/index.html) >"A coronavirus vaccine being developed by Novavax appears safe and elicits an immune response, according to a study published Wednesday in The New England Journal _...Read More_
[https://amp.cnn.com/cnn/2020/09/02/health/novavax-vaccine-safe/index.html](https://amp.cnn.com/cnn/2020/09/02/health/novavax-vaccine-safe/index.html) >"A coronavirus vaccine being developed by Novavax appears safe and elicits an immune response, according to a study published Wednesday in The New England Journal _...Read More_
0
3
0
3
[https://m.timesofindia.com/india/serum-institute-caps-proposed-vaccine-price-at-rs-225/dose/articleshow/77424541.cms](https://m.timesofindia.com/india/serum-institute-caps-proposed-vaccine-price-at-rs-225/dose/articleshow/77424541.cms)
[https://m.timesofindia.com/india/serum-institute-caps-proposed-vaccine-price-at-rs-225/dose/articleshow/77424541.cms](https://m.timesofindia.com/india/serum-institute-caps-proposed-vaccine-price-at-rs-225/dose/articleshow/77424541.cms)
0
224
0
224